Psychotropic Medication Monitoring and Diagnosis Documentation Deficiencies
Summary
The facility failed to ensure that residents receiving antipsychotic and antidepressant medications had appropriate diagnoses and were monitored for side effects as recommended by the pharmacist for two residents. The deficiency involved Resident 127 and Resident 16, both of whom were receiving psychotropic medications and had documentation issues related to diagnosis verification and monitoring of medication-related adverse effects. Resident 127 was admitted with a diagnosis of paranoid schizophrenia, and the MDS assessments also documented paranoid schizophrenia as an active diagnosis. However, the most recent geriatric psychiatry note listed a past history of major neurocognitive disorder and psychosis not otherwise specified, and earlier hospital records reflected psychosis with rule out substance-induced versus neurocognitive disorder, without a diagnosis of paranoid schizophrenia. The resident had orders for olanzapine, including a PRN order for psychosis, a bedtime order for schizophrenia, and a morning order for paranoid schizophrenia. Nursing documentation began marking akathisia on the medication record starting on the night shift of August 23 and continuing each shift thereafter, and the resident was observed frequently moving from sitting to standing, stating he could not seem to be still and that the feeling had started in the last three months. The record review found no nursing progress note documenting that the physician or psychiatrist was informed of the new symptom of akathisia. Resident 16 had diagnoses including a history of major depressive disorder and was documented on the MDS as rarely or never understood with severe cognitive deficits. The medication record reconciliation identified a pharmacist recommendation warning that trazodone and sertraline coadministration may lead to serotonin syndrome and listed symptoms to observe for, with the physician response noted as “will obs.” The MAR did not show that serotonin syndrome symptoms were being observed or monitored during the months reviewed. Resident 16 had orders for trazodone at bedtime for depression and sertraline daily for depression, and during observation was seen mumbling to self, unable to carry on a conversation, with hand tremors, jerking legs, and repeated attempts to stand from the wheelchair. Staff stated the tremors were normal for him, that he was a fall risk, and that he was not being monitored for serotonin syndrome. The facility was unable to provide a policy and procedure for psychotropic medication use and/or monitoring.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.